Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

3.65
Delayed Data
As of Apr 20
 +0.02 / +0.55%
Today’s Change
2.58
Today|||52-Week Range
5.66
+26.74%
Year-to-Date
No recent news for Achillion Pharmaceuticals Inc.

Today’s Trading

Previous close3.63
Today’s open3.61
Day’s range3.60 - 3.70
Volume462,699
Average volume (3 months)2,215,740
Market cap$583.3M
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)-37.78%
Earnings growth (this year)+10.22%
Earnings growth (next 5 years)+5.23%
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book1.80

Competitors

 Today’s
change
Today’s
% change
ITCIIntra-Cellular Thera...-0.36-1.85%
SGYPSynergy Pharmaceutic...-0.03-1.69%
INSYINSYS Therapeutics I...+0.07+1.01%
MGNXMacroGenics Inc+0.05+0.21%
Data as of 4:00pm ET, 04/20/2018

Financials

Next reporting dateMay 9, 2018
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$0.00
Annual profit (last year)-$85.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Milind S. Deshpande
President &
Chief Operating Officer
Joseph Truitt
Corporate headquarters
New Haven, Connecticut

Forecasts